Haroun Gajraj: Stop Before You Inject Spider Veins Around the Ankle
Haroun Gajraj, Phlebologist and Board Member of the British Association of Sclerotherapists, posted on LinkedIn:
“STOP: BEFORE YOU INJECT SPIDER VEINS AROUND THE ANKLE…
Consider these 4…
The ankle region is one of the RISKIEST areas in Sclerotherapy.
Even experienced practitioners can face complications that lead to months of patient pain.
Here are the 4 crucial factors that make this zone a clinical minefield:
1. Arterial Vulnerability
This zone is uniquely prone to inadvertent injection into tiny arterioles, or sometimes arteries, with potentially disastrous consequences.
2. Protracted Pain
Extravasation of sclerosant can easily inflame a superficial sensory nerve, leading to sharp pain that persists for weeks, and often months.
3. Slow Healing
Any resulting scabs or skin ulcers typically take a considerably longer time to heal compared to other areas of the leg.
4. Venous Reflux
Spider veins here are more strongly associated with underlying venous reflux, meaning superficial treatment alone may not address the root cause.
If you are treating this area, you must know the correct technique and mitigation strategies to protect your patient and your practice.
I have shared my full approach and detailed advice in a video. Watch the expert technique and full warning here.
I’m REALLY interested to hear from other experienced specialists.
For experienced practitioners: Which specific sclerosant and concentration do you prefer for the ankle, and why?
Let’s discuss best practices in the comments!
Acknowledgment: Injection technique demonstrated by Zola Mzimba board member of The British Association of Sclerotherapists
Disclaimer
- This content is for educational purposes only and is intended for medical professionals (Sclerotherapists, Phlebologists, etc.). It does not constitute specific medical advice, diagnosis, or treatment for any individual. Always rely on your own clinical judgment, training, and patient assessment before performing procedures.”

Stay informed with Hemostasis Today.
-
Jul 9, 2026, 14:27Dima Shulkin: Next-Generation AI Models Improve Early Sepsis Recognition
-
Jul 9, 2026, 14:12Omar Hajji: Seasonal Determinants of Mortality in Sepsis and Cardiogenic Shock
-
Jul 9, 2026, 13:54Hussein Yassine: Why Omega-3s May Fall Short in Preventing Alzheimer’s Disease
-
Jul 9, 2026, 13:16Olivier Mathieu: Innovating the Future of Hemostasis at ISTH 2026
-
Jul 9, 2026, 12:41Thomas Palmer-Dench: Hexokinase Controls Platelet Activation and Hemostasis
-
Jul 9, 2026, 12:19Paschalis Evangelidis: Join Our Special Issue on Thrombosis and Vascular Disorders
-
Jul 9, 2026, 12:16Fernanda Betti Solano: Could Iron Deficiency Be Affecting Your Sleep?
-
Jul 9, 2026, 12:08Andreas Calatzis: What is the Rationale for Collagen-Induced Platelet Aggregation Testing?
-
Jul 9, 2026, 11:54Deepak Pradhan։ Can Withaferin-A Help Combat Drug-Resistant Malaria?